David Waltz

Years Active: 2018-2018
Publications (10 Years): 1

Vertex Pharmaceuticals Inc

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Vertex Pharmaceuticals Inc

United States

Senior Medical Director :: CF Medical Directors

Publications

Steven M Rowe, Susanna A McColley, Ernst Rietschel, Xiaolei Li, Scott C Bell, Michael W Konstan, Gautham Marigowda, David Waltz, Michael P Boyle, null null
Lumacaftor/Ivacaftor Treatment of Patients with Cystic Fibrosis Heterozygous for F508del-CFTR. Annals of the American Thoracic Society 14 (2) (2018)

David Waltz.css-eqlu8i{font-size:small;padding-left:4px;}